The Thermolabile Variant of Methylenetetrahydrofolate Reductase (MTHFR) is Not a Major Risk Factor for Neural Tube Defect in American Caucasians. The NTD Collaborative Group
Overview
Affiliations
Mutations in the gene for methylenetetrahydrofolate reductase (MTHFR) have been implicated as a risk factor in the formation of neural tube defects. We investigated this gene in a series of 65 sporadic American Caucasian patients with lumbosacral NTD and their unaffected parents, using both case-control design and assessment of linkage disequilibrium. We found no evidence to support mutations in MTHFR as a significant risk factor for NTD in this population.
Folate action in nervous system development and disease.
Balashova O, Visina O, Borodinsky L Dev Neurobiol. 2018; 78(4):391-402.
PMID: 29380544 PMC: 5867258. DOI: 10.1002/dneu.22579.
Balashova O, Visina O, Borodinsky L Development. 2017; 144(8):1518-1530.
PMID: 28255006 PMC: 5399658. DOI: 10.1242/dev.137315.
Yadav U, Kumar P, Yadav S, Mishra O, Rai V Metab Brain Dis. 2014; 30(1):7-24.
PMID: 25005003 DOI: 10.1007/s11011-014-9575-7.
Variants in maternal COMT and MTHFR genes and risk of neural tube defects in offspring.
Liu J, Zhang Y, Jin L, Li G, Wang L, Bao Y Metab Brain Dis. 2014; 30(2):507-13.
PMID: 24990354 DOI: 10.1007/s11011-014-9582-8.
Soldano K, Garrett M, Cope H, Rusnak J, Ellis N, Dunlap K Birth Defects Res B Dev Reprod Toxicol. 2013; 98(5):365-73.
PMID: 24323870 PMC: 4169175. DOI: 10.1002/bdrb.21079.